Wangzhong (Wang) S.

Wang S. has worked in the pharmaceutical industry since 2017. In that time, they have held roles at ChromoLogic LLC, Celgene, Bristol Myers Squibb, Cellmyx, and Capstan Therapeutics, and is currently a Senior Scientist in Formulation Development at ADARx Pharmaceuticals Inc. At ChromoLogic LLC, their role as Research Scientist included executing on a Phase I SBIR program and contributing to the writing of the Phase II application. At Celgene, they were promoted to Scientist II. At Bristol Myers Squibb, they utilized various formulation methods/techniques to overcome challenging problems in drug delivery. At Cellmyx, they were the Chief Scientific Officer. At Capstan Therapeutics, they are a Scientist II.

Wang S. attended Cornell University from 2008 to 2012, where they obtained a B.S. in Materials Science and Engineering. Wangzhong (Wang) then went on to receive a Doctor of Philosophy (Ph.D.) in Materials Science Engineering from UC San Diego in 2017.